Comparative Analgesic Effect After Total Knee Arthroplasty Between Intraosseous and Peri-articular Injection
Launched by THAMMASAT UNIVERSITY HOSPITAL · Jan 23, 2025
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Intra-operatively, you will be randomly assigned to receive intraosseous multimodal analgesic agent injection or peri-articular multimodal analgesic agent injection along with other standard medications. In the intraosseous injection group: Participants received combinations of 0.5% bupivacaine 100 mg + 0.1% adrenaline 0.6 mg + Morphine 5mg + Ketorolac 30 mg (totally 22 ml) which divided by 12 ml inject into intramedullary canal before bone plug impaction to close the canal and 10 ml inject into metaphysis of tibia before cementation and implantation. In the peri-articualr injection group: ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 50 - 80 yrs of age ASA classification: 1-3 Unilateral TKA
- Exclusion Criteria:
- • Secondary OA knee Previous knee surgery Can't undertaken spinal block and adductor canal block Renal insuf. (Crcl \< 30 ml/min) History of convulsive disorder Abnormal liver function BMI \> 35 Kg/M2 Allergy to study drugs History of coronary disease Hb \< 10 (g/dl) Can't understand 100mm-VAS assessment Refuse to recruit in the study, or refuse follow up Using opioid in 5 days before surgery Unstable vital sign History current VTE Using anti-platelet or anti-coagulation medicine Severe deformity
About Thammasat University Hospital
Thammasat University Hospital is a leading academic medical institution in Thailand, dedicated to advancing healthcare through innovative research and clinical trials. Affiliated with Thammasat University, the hospital integrates education, research, and patient care, fostering an environment that promotes scientific inquiry and the development of new therapeutic interventions. With a commitment to excellence, Thammasat University Hospital collaborates with various stakeholders to conduct rigorous clinical trials that aim to improve patient outcomes and contribute to the global medical community. Its multidisciplinary team of healthcare professionals ensures the highest standards of ethics and safety in all research activities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Khlong Luang, Pathum Thani, Thailand
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported